IMMT and hypertrophic cardiomyopathy: Yet both chemicals led to enrichment of GO terms associated with motor proteins and cytoskeletal function, with carbofuran showing enrichment for pathways linked to concentric hypertrophic cardiomyopathy, a phenotype previously linked to motor protein disruption (Herron et al., 2008; Hein et al., 2000).